Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying TherapiesSusana Sainz de la Maza, Luisa María Villar, Alexander Rodero-Romero et al.|Vaccines|2023Cited by 7
Dabigatran in Secondary Stroke Prevention: Clinical Experience with 106 PatientsAlicia DeFelipe-Mimbrera, Jaime Masjuán, A. Alonso Cánovas et al.|BioMed Research International|2014Cited by 5